SCHEMBL8895903

SCHEMBL8895903

O=C1C(=O)c2cc3cc4ccccc4cc3cc2C=C1N[N+](=O)[O-]

nearest known ligand 0.33

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PTPRC P08575 2/20 0.33
CYP3A4 P08684 2/20 0.33
BCHE P06276 1/20 0.33
ACHE P22303 1/20 0.33
CES1 P23141 1/20 0.33
S100A4 P26447 1/20 0.33
ALDH1A1 P00352 1/20 0.30
TP53 P04637 1/20 0.30
CYP1A2 P05177 1/20 0.30
CYP2D6 P10635 1/20 0.30
CYP2C9 P11712 1/20 0.30
MAPK1 P28482 1/20 0.30
CYP2C19 P33261 1/20 0.30
STAT6 P42226 1/20 0.30
HIF1A Q16665 1/20 0.30
PHLPP2 Q6ZVD8 1/20 0.30
HSD17B10 Q99714 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8895041 0.79 CYP3A4 (0.40) PTPRCCYP3A4BCHEACHECES1
SCHEMBL28158596 0.75 L3MBTL1 (0.35) PTPRCBCHECES1S100A4ALDH1A1
SCHEMBL4910366 0.75 PTPRC (0.41) PTPRCCYP3A4BCHEACHECES1
SCHEMBL11483329 0.73 NPC1 (0.33) MAPK1
SCHEMBL18450874 0.73 MAPT (0.50) CYP3A4ALDH1A1TP53MAPK1HSD17B10
SCHEMBL7898478 0.70 ALDH1A1 (0.39) PTPRCCYP3A4BCHECES1S100A4
SCHEMBL9405259 0.70 CES1 (0.47) PTPRCCYP3A4BCHECES1S100A4
SCHEMBL7945702 0.70 ALDH1A1 (0.39) PTPRCCYP3A4BCHECES1S100A4
SCHEMBL10942136 0.70 ALDH1A1 (0.36) PTPRCCYP3A4BCHECES1S100A4
SCHEMBL2974052 0.69 HKDC1 (0.55) CYP3A4CYP1A2CYP2D6CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5594158-A Processes for producing doxorubicin, daunomycinone, and derivatives of doxorubicin THE BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA (US) 1997-01-14 US disclosed
EP-0523289-A1 Processes for producing doxorubicin, daunomycinone, and derivatives of doxorubicin Board of Regents of the University of Nebraska (US) 1993-01-20 EP disclosed